Alzheimer’s Research & Therapy (Jun 2024)

Brain age as a biomarker for pathological versus healthy ageing – a REMEMBER study

  • Mandy M.J. Wittens,
  • Stijn Denissen,
  • Diana M. Sima,
  • Erik Fransen,
  • Ellis Niemantsverdriet,
  • Christine Bastin,
  • Florence Benoit,
  • Bruno Bergmans,
  • Jean-Christophe Bier,
  • Peter Paul de Deyn,
  • Olivier Deryck,
  • Bernard Hanseeuw,
  • Adrian Ivanoiu,
  • Gaëtane Picard,
  • Annemie Ribbens,
  • Eric Salmon,
  • Kurt Segers,
  • Anne Sieben,
  • Hanne Struyfs,
  • Evert Thiery,
  • Jos Tournoy,
  • Anne-Marie van Binst,
  • Jan Versijpt,
  • Dirk Smeets,
  • Maria Bjerke,
  • Guy Nagels,
  • Sebastiaan Engelborghs

DOI
https://doi.org/10.1186/s13195-024-01491-y
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Objectives This study aimed to evaluate the potential clinical value of a new brain age prediction model as a single interpretable variable representing the condition of our brain. Among many clinical use cases, brain age could be a novel outcome measure to assess the preventive effect of life-style interventions. Methods The REMEMBER study population (N = 742) consisted of cognitively healthy (HC,N = 91), subjective cognitive decline (SCD,N = 65), mild cognitive impairment (MCI,N = 319) and AD dementia (ADD,N = 267) subjects. Automated brain volumetry of global, cortical, and subcortical brain structures computed by the CE-labeled and FDA-cleared software icobrain dm (dementia) was retrospectively extracted from T1-weighted MRI sequences that were acquired during clinical routine at participating memory clinics from the Belgian Dementia Council. The volumetric features, along with sex, were combined into a weighted sum using a linear model, and were used to predict ‘brain age’ and ‘brain predicted age difference’ (BPAD = brain age–chronological age) for every subject. Results MCI and ADD patients showed an increased brain age compared to their chronological age. Overall, brain age outperformed BPAD and chronological age in terms of classification accuracy across the AD spectrum. There was a weak-to-moderate correlation between total MMSE score and both brain age (r = -0.38,p < .001) and BPAD (r = -0.26,p < .001). Noticeable trends, but no significant correlations, were found between BPAD and incidence of conversion from MCI to ADD, nor between BPAD and conversion time from MCI to ADD. BPAD was increased in heavy alcohol drinkers compared to non-/sporadic (p = .014) and moderate (p = .040) drinkers. Conclusions Brain age and associated BPAD have the potential to serve as indicators for, and to evaluate the impact of lifestyle modifications or interventions on, brain health.

Keywords